156 related articles for article (PubMed ID: 33935737)
21. Antitumor effect of a copper (II) complex of a coumarin derivative and phenanthroline on lung adenocarcinoma cells and the mechanism of action.
Zhu T; Chen R; Yu H; Feng Y; Chen J; Lu Q; Xie J; Ding W; Ma T
Mol Med Rep; 2014 Nov; 10(5):2477-82. PubMed ID: 25176185
[TBL] [Abstract][Full Text] [Related]
22. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma.
Deng L; Yang J; Chen H; Ma B; Pan K; Su C; Xu F; Zhang J
Onco Targets Ther; 2016; 9():325-33. PubMed ID: 26834491
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable hydrogel from pectin and carboxymethyl cellulose with Silibinin loading for lung tumor therapy.
Yin L; Duan W; Chen Y; Chen D; Wang Y; Guo S; Qin J
Int J Biol Macromol; 2023 Jul; 243():125128. PubMed ID: 37268066
[TBL] [Abstract][Full Text] [Related]
25. Increased TMEM16A Involved in Alveolar Fluid Clearance After Lipopolysaccharide Stimulation.
Li H; Yan X; Li R; Zhang A; Niu Z; Cai Z; Duan W; Li X; Zhang H
Inflammation; 2016 Apr; 39(2):881-90. PubMed ID: 26899569
[TBL] [Abstract][Full Text] [Related]
26. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
27. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
[TBL] [Abstract][Full Text] [Related]
28. TMEM16A-inhibitor loaded pH-responsive nanoparticles: A novel dual-targeting antitumor therapy for lung adenocarcinoma.
Guo S; Qiu L; Chen Y; Wang X; Ma B; Qu C; Cui J; Zhang H; Xing C; Zhan Y; An H
Biochem Pharmacol; 2020 Aug; 178():114062. PubMed ID: 32492446
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of CaCC
Shi S; Guo S; Chen Y; Sun F; Pang C; Ma B; Qu C; An H
Arch Biochem Biophys; 2020 Nov; 695():108650. PubMed ID: 33132191
[TBL] [Abstract][Full Text] [Related]
30. Self-healing pectin/cellulose hydrogel loaded with limonin as TMEM16A inhibitor for lung adenocarcinoma treatment.
Chang L; Chang R; Shen J; Wang Y; Song H; Kang X; Zhao Y; Guo S; Qin J
Int J Biol Macromol; 2022 Oct; 219():754-766. PubMed ID: 35961552
[TBL] [Abstract][Full Text] [Related]
31. Silibinin inhibits migration and invasion of the rhabdoid tumor G401 cell line via inactivation of the PI3K/Akt signaling pathway.
Li Y; Zhang C; Cai D; Chen C; Mu D
Oncol Lett; 2017 Dec; 14(6):8035-8041. PubMed ID: 29344246
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
33. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
34. TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer.
Hu C; Zhang R; Jiang D
Arch Iran Med; 2019 Jan; 22(1):32-38. PubMed ID: 30821158
[TBL] [Abstract][Full Text] [Related]
35. Effect of silibinin on the growth and progression of primary lung tumors in mice.
Singh RP; Deep G; Chittezhath M; Kaur M; Dwyer-Nield LD; Malkinson AM; Agarwal R
J Natl Cancer Inst; 2006 Jun; 98(12):846-55. PubMed ID: 16788158
[TBL] [Abstract][Full Text] [Related]
36. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
[TBL] [Abstract][Full Text] [Related]
37. Silibinin promotes the apoptosis of gastric cancer BGC823 cells through caspase pathway.
Li R; Yu J; Wang C
J BUON; 2017; 22(5):1148-1153. PubMed ID: 29135096
[TBL] [Abstract][Full Text] [Related]
38. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of TMEM16A calcium-activated chloride channel contributes to cerebrovascular remodeling during hypertension by promoting basilar smooth muscle cell proliferation.
Wang M; Yang H; Zheng LY; Zhang Z; Tang YB; Wang GL; Du YH; Lv XF; Liu J; Zhou JG; Guan YY
Circulation; 2012 Feb; 125(5):697-707. PubMed ID: 22215857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
